News Arkin Capital Closes $100M Arkin Bio Ventures III to Back Advanced Pre-Clinical to Early Clinical-Stage Biotech Companies –Healthradar13. Januar 2026 What You Should Know: – Arkin Capital, a leading multi-asset investment manager, today announced the closing of Arkin Bio Ventures…
